Bristol Who’s Who Recognizes Eugene Moore
INVESTORS! Exciting New Investment Opportunity
If you are an angel investor looking to be part of an exciting opportunity that benefits animal welfare, please read on…
We are an early-stage, consumer-facing, veterinary diagnostics company. Utilizing cost-efficient advanced molecular diagnostics, it will be possible for the first-time to provide information specific to your pet’s cancer that will guide the drug selection process, indicate prognosis, and monitor treatment resistance. Due to a lack of regulatory oversight and our partnership with Veterinary Specialty Hospital in San Diego, CA, through their contribution of management experience and distribution channels, we are poised to achieve a full sales program within seven months of being fully capitalized.
If you are interested in more details about this investment opportunity, please contact me directly at gene.moore@transcribDx.com.
I would be happy to discuss the opportunity, and provide and executive summary and slide deck for your review.
Eugene Moore is the Co-founder and Owner of TranscribDx, established in 2009, a start-up molecular diagnostics company serving the veterinary oncology community. Dr. Moore specializes in veterinary molecular oncology and veterinary medicine and has an extensive background in protein chemistry, mass spectrometry, molecular biology, immunohistochemistry and electrophysiology.
TranscribDx is developing and commercializing the use of next-generation sequencing and quantitative real-time PCR platforms for advanced cancer testing in companion animals. TranscribDx provides first-to-scale, consumer-facing veterinary genetic testing that will make it possible for veterinarians and pet parents alike to make a well-informed quality of life decision regarding their pet’s cancer treatment options. TranscribDx has fostered a partnership with Veterinary Specialty Hospital in San Diego, CA, who is providing extensive management experience and nationwide sales distribution channels. In addition, La Jolla Institute for Allergy and Immunology is providing incubator lab space and equipment for proof-of-concept product development.
Eugene Moore holds a Doctorate in Biochemistry and Molecular Biology, received in 2004 from the University of California, Riverside, and has extensive training in biochemical and molecular analysis ranging from HPLC/MS, RT-PCR, neuroscience, and DNA sequencing. Eugene is a member of the American Chemical Society, Veterinary Cancer Society, and the Humane Society. Dr. Moore is also currently working on a fully validated NGS-based haplotyping pipeline in conjunction with La Jolla Institute for Allergy and Immunology.
Bristol Who’s Who Member Eugene Moore can be found on the Who’s Who Directory where he is looking forward to networking with you.
